In contrast, high expression of STXBP2 was a protective factor in BLCA (Bladder Urothelial Carcinoma), SARC (Sarcoma), SKCM, THYM (Thymoma), and CHOL (Cholangiocarcinoma) (Figure S3). Here, STXBP2 is linked to bladder transitional cell carcinoma.